论文部分内容阅读
目的 观察脑复康治疗急性脑梗死的疗效。方法 选择住院的急性脑梗死病人 96例 ,随机分为治疗组 46例 :脑复康 10g静滴 ,1次 /天 ;对照组 5 0例 :胞二磷胆碱 1.0 g静滴 ,1次 /天 ,两组均采用 14天为一疗程 ,间隔 3天后行第二疗程 ,两疗程结束后评定临床疗效。结果 治疗组总显效率 80 .4% ,基本痊愈率34.8% ;对照组总显效率 5 6 % ,基本痊愈率 16 % ,经统计学处理 ,两组疗效有显著性差异 (P <0 .0 5 )。结论 脑复康治疗急性脑梗死的疗效好 ,无明显不良反应 ,值得临床推广。
Objective To observe the curative effect of naofukang on acute cerebral infarction. Methods A total of 96 patients with acute cerebral infarction were selected and randomly divided into treatment group (n = 46): nifukang 10g intravenously, once a day, while control group (n = 50) Day, the two groups were used for 14 days for a course of treatment, after a lapse of 3 days after the second course of treatment, after the end of two courses to assess the clinical efficacy. Results The total effective rate was 80.4% in the treatment group and the basic cure rate was 34.8%. The total effective rate in the control group was 56% and the basic recovery rate was 16%. The statistical difference between the two groups was significant (P <0. 0 5). Conclusion Naofukang is effective in treating acute cerebral infarction with no obvious adverse reactions and is worthy of clinical promotion.